For identification purpose only
A N N U A L R E P O R T
2 0 18
CONTENTS
Abbreviations | 2 |
Corporate Information | 3 |
Chairman's Statement | 4 |
Management Discussion and Analysis | 5 |
Environmental, Social and Governance Report | 11 |
Biographical Details of Directors | 24 |
Report of the Directors | 27 |
Corporate Governance Report | 34 |
Independent Auditor's Report | 44 |
Consolidated Statement of Profit or Loss | 51 |
Consolidated Statement of Profit or Loss and Other Comprehensive Income | 52 |
Consolidated Statement of Financial Position | 53 |
Consolidated Statement of Changes in Equity | 55 |
Consolidated Statement of Cash Flows | 56 |
Notes to the Consolidated Financial Statements | 58 |
Five Years Financial Summary | 158 |
ANNUAL REPORT 2018 | 1 |
ABBREVIATIONS
In this annual report, the following abbreviations have the following meanings unless otherwise specified:
"Board" | the Board of Directors of the Company |
"Company" | Winshine Science Company Limited |
"Directors" | the directors of the Company |
"Group" | the Company and its subsidiaries |
"Listing Rules" | the Rules Governing the Listing of Securities on the Stock |
Exchange | |
"PRC" | the People's Republic of China, for the purpose of this report, |
excluding Hong Kong, Macau and Taiwan | |
"SFO" | the Securities and Futures Ordinance (Chapter 571 of the |
Laws of Hong Kong) | |
"Stock Exchange" | The Stock Exchange of Hong Kong Limited |
"HK$" and "HK cents" | Hong Kong dollars and cents |
"RMB" | Renminbi |
"US$" | United States dollars |
"%" | per cent. |
2 | WINSHINE SCIENCE COMPANY LIMITED |
BOARD OF DIRECTORS
Executive Directors
Mr. Zhao Deyong (Chairman)
(appointed on 16 May 2019)
Mr. Liu Michael Xiao Ming (Chief Executive Officer) (appointed on 10 May 2019)
Mr. Luo Lianjun (appointed on 10 May 2019)
Mr. Xing Wei (Chairman)
(removed on 10 May 2019)
Mr. Wei Guo (Chief Executive Officer) (removed on 10 May 2019)
Non-executive Director
Mr. Lin Shaopeng
Independent Non-executive Directors
Mr. Kwok Kim Hung Eddie
- (appointed on 7 March 2019) Mr. Ng Wai Hung
- (appointed on 21 May 2019) Ms. Shi Xiaolei
- (appointed on 21 May 2019) Mr. Li Fang
- (resigned on 7 March 2019) Mr. Lau Shun Pong Johnson
- (resigned on 10 April 2019) Mr. Lai Ming Wai
- (resigned on 11 April 2019)
AUDIT COMMITTEE
Mr. Kwok Kim Hung Eddie (Chairman)
Mr. Ng Wai Hung
Ms. Shi Xiaolei
REMUNERATION COMMITTEE
Ms. Shi Xiaolei (Chairman)
Mr. Kwok Kim Hung Eddie
Mr. Ng Wai Hung
NOMINATION COMMITTEE
Mr. Ng Wai Hung (Chairman)
Mr. Kwok Kim Hung Eddie
Ms. Shi Xiaolei
COMPANY SECRETARY
Mr. Lau On Kwok
- (resigned on 13 November 2018) Mr. Shoom Chin Wan
- (appointed on 10 December 2018 and
- resigned on 7 March 2019)
Mr. Yip Chun Chung
(appointed on 7 March 2019)
CORPORATE INFORMATION
TRADING OF SHARES
The Stock Exchange of Hong Kong Limited (Stock Code: 209)
REGISTERED OFFICE
Clarendon House
2 Church Street
Hamilton HM 11
Bermuda
HEAD OFFICE AND PRINCIPAL PLACE OF BUSINESS IN HONG KONG
Rooms 2202-2203, 22/F.
Harbour Centre
25 Harbour Road
Wanchai, Hong Kong
PRINCIPAL BANKERS
The Hongkong and Shanghai Banking
Corporation Limited
Bank of Communications Co. Ltd.
- Hong Kong Branch Guangdong Development Bank
- Zhongshan Branch
AUDITOR
Moore Stephens CPA Limited
PRINCIPAL SHARE REGISTRAR AND TRANSFER OFFICE
MUFG Fund Services (Bermuda) Limited 4th floor North, Cedar House,
41 Cedar Avenue, Hamilton HM 12, Bermuda
HONG KONG BRANCH SHARE
-
REGISTRAR AND TRANSFER OFFICE
Tricor Tengis Limited Level 54, Hopewell Centre 183 Queen's Road East, Hong Kong
WEBSITE
http://www.winshine.com
http://www.tricor.com.hk/webservice/000209
ANNUAL REPORT 2018 | 3 |
CHAIRMAN'S STATEMENT
Dear follow shareholders:
The board (the "Board") of directors (the "Directors") of Winshine Science Company Limited (the "Company") herein presents the audited annual results of the Company and its subsidiaries (together, the "Group") for the financial year ended 31 December 2018. The Group mainly engages in the existing businesses of manufacturing and trading of toys, securities investment and research and development in medical and health products.
We had a challenging year in 2018 as the Group's equity position was further eroded by the losses from a significant asset impairment due to the legacy issues that we had to resolve to meet the accounting rules and prepare for a more profitable future. In addition, our toys division continues to face headwinds as intense industry competition and trade wars render the business less profitable.
PROSPECTS
The Company is having significant changes in the year 2019 in terms of board of directors and the financial statements. The board of directors were all newly appointed in the year 2019 and the new board immediately implemented policies to set the Company in a right direction. The new board is looking for different business opportunity to diversify our principal business activities. Cost cutting measures were put in place to reduce operating costs. The Board appointed an independent investigator to look into the allegations made by previous auditor and determine the appropriate action to follow up. The new Board engaged an independent consultant to review and eliminate potential internal control weakness. On our financial statements, the Company cleared long outstanding debt and obtained new extension of loans to give the Company a better financial position to meet the future challenge.
The toys division is expected to continue to perform satisfactorily. Due to the trade conflict between the US and China, and the related customs duty increase, customers are cautious to place orders. Besides, customers are actively looking for productions bases outside China to alleviate the possible tariffs and possible lower cost of production. Those trends may cause extreme pressure on product margins and turnover, in particular the first half in 2019. However, stabilized RMB and lower material cost will be favorable in 2019.
Looking forward, we are cautiously optimistic as our toys division continues to perform successfully in the marketplace and the new Board sets to start to explore new business opportunity on a much lower management cost.
Zhao Deyong
Chairman
4 | WINSHINE SCIENCE COMPANY LIMITED |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
Winshine Science Co. Ltd. published this content on 04 November 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 November 2019 23:52:07 UTC